THE USE OF UROKINASE IN SCRIBNER SHUNTS.

Autor: HARTLEY, L. C. J., ELLIS, F. G., RENDALL, MAX, CAMERON, J. S., OGG, C. S.
Zdroj: British Journal of Urology; 1970, Vol. 42 Issue 2, p246-249, 4p
Abstrakt: SUMMARY In the management of clotting in Scribner shunts, urokinase was of value in removing clot and thereby extending shunt life. During a trial involving 16 shunts over 40.5 patient months, no significant benefit was detected from the introduction of urokinase into the venous side of the shunt prior to each dialysis. [ABSTRACT FROM AUTHOR]
Databáze: Complementary Index